W. Gaebel, Germany

Dr. med. Wolfgang Gaebel is Professor of Psychiatry, former Director of the Department of Psychiatry and Psychotherapy at the Heinrich-Heine University, Düsseldorf (Germany), and Head of the LVR-Klinikum Düsseldorf. He is Director of the WHO Collaborating Centre on Quality Management and Empowerment in Mental Health. From 2014 to 2016 he was also Founding Director of the LVR-Institute for Mental Healthcare Research in Düsseldorf. Prof. Gaebel was twice President of the German Society of Psychiatry, Psychotherapy and Psychosomatics (DGPPN 1995/6, 2007/8) and he was President of the European Psychiatric Association (EPA 2015/6) and is Co-chair of the EPA Section on Schizophrenia and Co-chair of the EPA Publication Com-mittee. He is chairing the World Psychiatric Association (WPA) Sections on Schizophrenia and on Quality Assurance. His research focus includes clinical, pharmacological, and neurophysiological aspects of schizophrenia, treatment guidelines and quality management, stigma and discrimination, and the revision of classification towards DSM-5 and ICD-11. He was a member of the WHO International Advisory Group for the Revision of ICD-10 Mental and Behavioral Disorders, chaired the ICD-11 working group on Psychotic Disorders, he was a member of the WHO ICD-11 Field Study Coordination Group and is a member of the WHO FIC Medical Scientific Advisory Committee for ICD-11. In 2020 Prof. Gaebel was honored by the DGPPN with the Wilhelm-Griesinger Medal as a lifetime reward.

Moderator Of 3 Sessions

Date
Mon, 12.04.2021
Session Time
15:30 - 17:00
Room
Channel 4
Session Description
The Live Q&A of this session will take place in the Live Sessions auditorium. Please refer to the interactive programme for the exact time and channel.

The work of psychiatrists has been profoundly disrupted by the COVID-19 pandemic (e.g., redeployment, shifting institutional priorities, sudden massive use of telehealth services). At the same time, mental health concerns in the population have been exacerbated by the pandemic (e.g., due to isolation, anxiety, substance use), resulting in increased need for services at a time when accessing services is more difficult. This symposium will present the results of two large longitudinal studies that speak to these issues. The first is a global, multilingual study of the impact of the COVID-19 pandemic on clinical practice and well-being of psychiatrists and other mental health professionals. Results will be presented from two waves of data collection with members of the World Health Organization's Global Clinical Practice Network (GCPN), comprising 15,500 clinicians from 159 countries. The first speaker will focus on predictors of distress, occupational burnout, and practice disruption over time and the use of distance technologies for evaluation and treatment. The second and third speakers will focus on China and Russia, examining impact on GCPN members as a function of the course of the pandemic in those countries. The fourth speaker will focus on the mental health impact of the COVID-19 pandemic among a representative sample of the general population of Madrid (n = 900), interviewed by telephone at two time points. The symposium will consider the implications of the results for the delivery of mental health services and for programs and policies that protect well-being and reduce occupational burnout among psychiatrists.

Session Icon
Pre-Recorded with Live Q&A
Clinical/Therapeutic
Date
Tue, 13.04.2021
Session Time
08:00 - 09:30
Room
Channel 3
Session Description
Proposed by the EPA section on Schizophrenia -The goal of schizophrenia treatment has shifted from symptom reduction and prevention of relapses to functional recovery. However, recovery rates remain very low. Early intervention and identification of predictors of clinical and functional outcome is essential to implement personalized and integrated treatment programs to prevent disability and promote recovery. Stratification of subjects with high-risk status, first-episode and chronic schizophrenia using several predictors of clinical and functional outcome might contribute to early recognition, treatment, rehabilitation and personalized care, promoting prevention of disability, independent leaving, social inclusion and user satisfaction. The symposium will present data in chronic and first-episode patients on predictors of clinical and functional outcome, along with perspectives on personalized and integrated management programs in subjects with schizophrenia and high-risk status.
Session Icon
Live, Section
Date
Sun, 11.04.2021
Session Time
10:00 - 11:30
Room
Channel 1
Session Description
Now is the time to place digital mental health at the heart of national and European health strategies to speed up implementation – especially in a global crisis like the present Covid-19 pandemic with physical distancing, societal lock-down, and psychosocial derangement by using telemental health, selfmanagement tools and other digital options.Mental health systems need a well-balanced combination of guidance, regulation, legislation and education, plus awareness campaigns to ensure that the use of safe, effective and high-quality digital mental health approaches is promoted to benefit the (mental) health of European citizens. More attention should be given to sensitising the public, developing needs-tailored approaches for specific target groups, improving training for the mental health workforce, and developing guidelines and transparent information about digital mental health products and services. More research is needed to identify how European citizens may effectively benefit from digital mental health approaches, including efficacy, cost-effectiveness and implementation strategies. To achieve these goals, the engagement of all stakeholders (health professionals, developers, users, and policy makers) is required.The presentation by Oyono Vlijter (Diemen, The Netherlands) describes how to overcome challenges for implementing digital mental health across Europe. Heleen Riper (Amsterdam, The Netherlands) gives an overview of research models and results with an eye on implementation efforts. Challenges and opportunities for the members of the EPA Council of National Psychiatric Associations in implementing digital mental health are presented by Simavi Vahip (Izmir, Turkey). Wolfgang Gaebel (Düsseldorf, Germany) is elucidating the role of a transnational policy for a concerted action planning in implementation.
Session Icon
Live

Presenter Of 4 Presentations

Symposium: The Impact of COVID-19 on Mental Health and Mental Health Professionals: Two Large Longitudinal Studies (ID 134) No Topic Needed
LIVE - Symposium: Improving Real-life Functioning in People with Schizophrenia: From Assessment to Integrated Treatment Plans (ID 294) No Topic Needed
LIVE - Symposium: Implementing Digital Mental Health Across Europe (ID 608) No Topic Needed

Live Q&A

Session Icon
Live
Date
Sun, 11.04.2021
Session Time
10:00 - 11:30
Room
Channel 1
Lecture Time
11:08 - 11:28
LIVE - Symposium: Implementing Digital Mental Health Across Europe (ID 608) No Topic Needed

S0020 - The Integrative Function of a Transnational Policy and Roadmap for Action Planning in Implementing Digital Mental Health

Session Icon
Live
Date
Sun, 11.04.2021
Session Time
10:00 - 11:30
Room
Channel 1
Lecture Time
10:51 - 11:08
Presenter

ABSTRACT

Abstract Body

In times of global crisis like the present Covid-19 pandemic, digital technology is rapidly conquering the health and mental health & care sector, speeding up e-Mental Health (eMH) implementation on a regional, national and global scale.

Making this an organized move, guidance and regulation, legislation and training, but basically also awareness and acceptance building need to ensure the use of efficient, safe and high-quality eMH products and services. Special attention needs to focus on broadening public and professional eMH literacy, providing needs-tailored approaches for target groups, and training mental health workforce and services. Guidance, evaluation and involvement of relevant stakeholders should help to identify how citizens will best benefit from eMH&Care in its various forms.

The Transnational Policy for e-Mental Health, a guidance document for European policymakers and stakeholders has been developed by the Interreg-funded eMEN project (www.nweurope.eu/emen) in six EU countries to promote implementation of high-quality eMH & care across NW-Europe. Project partners from Belgium, France, Germany, Ireland, the Netherlands and the UK contributed to product and policy-guidance development, promoting communication and research.

eMEN is currently continuing its work in the Interreg-funded ‎Capitalisation phase to scaling up the implementation of eMH&Care. The Transnational Policy within the scope of national information and training sessions on eMH will be promoted for action planning and implementation by policymakers and stakeholders at the national level. Further meetings will also take place at the European level to promote and support implementation of eMH&Care in NW-Europe and beyond.

Hide